Junfeng Sun
Impact in
- Biochemistry top 1%
- Blood transfusion and management
Papers in
-
- Bacillus and Francisella bacterial research 8
- Epidemiology 40
- Sepsis Diagnosis and Treatment 23
- Co-authors
- Charles Natanson (27 shared papers)Robert L. Danner (19 shared papers)Peter Q. Eichacker (31 shared papers)Steven B. Solomon (22 shared papers)Harvey G. Klein (14 shared papers)André C. Kalil (7 shared papers)Judith A. Welsh (11 shared papers)Xizhong Cui (23 shared papers)
- Journals
- Critical Care Medicine (14 papers)Transfusion (8 papers)Intensive Care Medicine Experimental (6 papers)PLoS ONE (6 papers)Clinical Infectious Diseases (4 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Junfeng Sun
154 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Critical Care and Intensive Care Medicine 431
- Biochemistry 437
- Applied Microbiology and Biotechnology 127
- Molecular Medicine 204
- Family Practice 85
Countries citing papers authored by Junfeng Sun
This map shows the geographic impact of Junfeng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Sun more than expected).
Fields of papers citing papers by Junfeng Sun
This network shows the impact of papers produced by Junfeng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Sun. The network helps show where Junfeng Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfeng Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 255 | |
| 2 | 2012 | 225 | |
| 3 | 2008 | 187 | |
| 4 | 2016 | 152 | |
| 5 | 2010 | 149 | |
| 6 | 2016 | 135 | |
| 7 | Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series — 465 Health Care Facilities, United States, December 2020–October 2021 Hit paper breakdown → | 2022 | 135 |
| 8 | 2012 | 124 | |
| 9 | 2007 | 117 | |
| 10 | 2019 | 111 | |
| 11 | 2011 | 94 | |
| 12 | 2021 | 84 | |
| 13 | 2010 | 83 | |
| 14 | 2020 | 82 | |
| 15 | 2019 | 81 | |
| 16 | 2013 | 79 | |
| 17 | 2017 | 72 | |
| 18 | 2011 | 56 | |
| 19 | 2007 | 55 | |
| 20 | 2013 | 53 |
About Junfeng Sun
Junfeng Sun is a scholar working on Molecular Biology, Epidemiology, Pulmonary and Respiratory Medicine, Surgery and Infectious Diseases, having authored 159 papers that have together received 4.6k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (23 papers), Blood transfusion and management (11 papers), Cancer-related molecular mechanisms research (10 papers), Hemoglobin structure and function (9 papers), Bacillus and Francisella bacterial research (8 papers), Disaster Response and Management (8 papers), Pulmonary Hypertension Research and Treatments (7 papers) and COVID-19 Clinical Research Studies (7 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (431 citations), Biochemistry (437 citations), Applied Microbiology and Biotechnology (127 citations), Molecular Medicine (204 citations) and Family Practice (85 citations). Junfeng Sun has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Charles Natanson, Robert L. Danner, Peter Q. Eichacker, Steven B. Solomon, Harvey G. Klein, André C. Kalil, Judith A. Welsh, Xizhong Cui, Anthony F. Suffredini and Dominique J. Pepper. Their work appears in journals such as Critical Care Medicine, Transfusion, Intensive Care Medicine Experimental, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.